Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion.

Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Abstract Text:

Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Publishing Authors By Initials

For similar body regions: thorax research abstracts see: body regions: thorax research

PUBMED ID PMID:

MEDLINE DATE:

Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 132

Page Numbers: 1105-6, 1108-9

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Sep

YEAR: 1996

Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Keywords Mesh Terms:

KEYWORDS: Thorax

MESH TERMS: pathology

Chemical & Substance for Abstract: Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Information

Substance Name: Arsenicals

Registry Number: 0

Grant and Affiliation Information for Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion.

AFFILIATION: Hospital of the University of Pennsylvania, Philadelphia, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Numerous erythematous truncal plaques Multiple basal cell carcinomas associated with arsenic ingestion Related Publications

• Activation of autoimmunity following use of immunostimulatory herbal supplements.
• CONTINUING EDUCATION: Is It Valid?
• Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
• Cutaneous lupus: insights into pathogenesis and disease classification.
• Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
• Dermatologic therapeutics: thalidomide. A practical guide.
• Dermatology vignette. Pseudoporphyria caused by NSAIDs.
• Development of outcome measures for autoimmune dermatoses.
• Failure of physiologic doses of pure UVA or UVB to induce lesions in photosensitive cutaneous lupus erythematosus: implications for phototesting.
• Lizard ecology: evidence of competition.
• Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center.
• Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion.
• Pathophysiology of cutaneous lupus erythematosus.
• RISK MANAGEMENT FOR CHIROPRACTORS AND OSTEOPATHS: Neck Manipulation & Vertebrobasilar Stroke.
• Regeneration of sulfur-fouled bimetallic Pd-based catalysts.
• Reliability of fMRI during a Continuous Motor Task: Assessment of Analysis Techniques.
• Risk Management for Chiropractors and Osteopaths. Informed consent: A Common Law Requirement.
• Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.
• The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology.
• The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
• Treatment of bullous pemphigoid with topical corticosteroids: review of a randomized controlled trial.
• Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
• Ulcerating skin lesions and arthritis after a crab bite.
• What is new in the treatment of steroid-induced osteoporosis?
• What is new in the treatment of steroid-induced osteoporosis?
• [Effect of malachite green on metabolism, especially on the enzymes of the respiratory chain in rats and their relation to the problem of abnormalities and carcinogenesis.]
• [Incidence of hereditary disorders caused by prolonged malachite green poisoning in rats; a contribution to chemogenesis.]
• [Methods of experimental research on cancer and its significance in practical medicine.]
• [The effect of malachite green on the growth of Walker rat carcinoma and Ehrlich mouse ascites tumor.]
• [The history of medicine. Richard Werth (1850-1918)]